Efficacy and safety of tongxinluo capsule for angina pectoris of coronary heart disease: an overview of systematic reviews and meta-analysis

BackgroundTongxinluo capsule (TXLC) is a common drug for treating angina pectoris of coronary heart disease (CHD). In recent years, many systematic reviews (SRs) and meta-analyses (MAs) have reported the efficacy and safety of TXLC for improving angina symptoms in patients with CHD. We aimed to comp...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Liuying Li, Peimin Feng, Wenhua Zhou, Biao Luo, Lvyu Deng, Daohui Gan, Xiaohan Wu, Fengya Zhu, Xia Zhou
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2024-02-01
Ráidu:	Frontiers in Cardiovascular Medicine
Fáttát:	tongxinluo capsule angina pectoris coronary heart disease overview traditional Chinese medicine
Liŋkkat:	https://www.frontiersin.org/articles/10.3389/fcvm.2024.1229299/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!